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stenosis in children and young adults is frequently encountered in
developing countries, and up to 25% of patients are younger than
20 years of age. This disease has been called juvenile mitral
stenosis.
Juvenile MS has been reported at very young age in the Indian
subcontinent.
We report a case of juvenile MS at 3 year age, the youngest ever
case reported
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Aims and objectives: To study the correlation between clinical
presentation of severe aortic stenosis with echocardiographic
measurements of left ventricle function and aortic valvular hemo-
dynamics including LV strain amongst its etiologies.
Materials and methods: This study has been performed from June
2013 to December 2014 in cardiology department at Sri Sathya Sai
Institute of Higher Medical Sciences in Puttaparthi, Anantapur
(Andhra Pradesh). Study included patients of severe AS coming
to cardiology OPD and who were willing for the study and were
eligible as per inclusion criteria. (Severe AS is deﬁned as aortic
valve area (by continuity equation) <1 cm2.)
Results:Total number of patients in study is 102.Male constitute 71
(70%) and females 31 (30%).
Mean age of presentation of rheumatic AS group 44 years, for
bicuspid group is 25 years and for degenerative group is 59 years.
Main symptoms of patient in all etiologies are dyspnoea, bicuspid
group 96% rheumatic 100%, degenerative 72%. Angina as a pre-
dominant symptom was seen 21% of patients with degenerative
group. Syncope was seen in 3 patients only. One in biscuspid group
and 2 in degenerative group.
All three group of patients had average AVA (Bicuspid 0.73
 0.01 cm2 Rheumatic 0.76 0.12 cm2 Degenerative 0.74
 0.08 cm2) and AVAI (Bicuspid 0.58 0.3 cm2/m2 Rheumatic 0.48
 0.09 cm2/m2 Degenerative 0.46 0.03 cm2/m2) in the range of
severe AS.
The average PG for (Bicuspid 96  30 mm Hg Rheumatic 93
 29 mm Hg Degenerative 93  31) and MG (B 62 R 56  19 D 55
 16) in the range of severe AS.
LV dimentions and LVH comparisons in etiologies.
Bicuspid Rheumatic Degenerative P value
LVIDd, mm 43  7.17 59  6.71 47  6.7 0.006
LVIDs, mm 26  6.19 31  4.8) 32  6.98 0.001
LVSd, mm 13  2 14  1.9 14  2.3 0.005
LVPWd, mm 12  2 13  1.6 14  1.7 0.001
LVMI g/m2 137  13 148  12 155  9 0.001
Comparison between SVI, LVEF and GLS between etiologies.
Bicuspid Rheumatic Degenerative P value
SVI ml/m2 60  4 59  3 56  5.2 0.001
LVEF % 67  8 64  9 59  9 0.008
GLS % 18  6.4 16  5 16  4 0.421
Therewas statistically signiﬁcant difference between SVI and LVEF
among the three groups. SVI and LVEFwere higher in patients with
bicuspid group compared to rheumatic and degenerative group
which suggest relatively better preserved LV systolic function in
bicuspid group
LV GLS assessment results showed that GLS was decreased in all 3
group. Degenerative and rheumatic group have more decrease in
GLS compared to bicuspid group but statistically not signiﬁcant.
Conclusions:
1. The clinical spectrum of Aortic stenosis is broad. And
patients with the same AVA can have different clinical
proﬁle, intracardiac hemodynamics and symptoms.
2. Patients with bicuspid aortic valve presents early, mean age
24 years, have less degree of LVH, less systolic and diastolic
dysfunction.
3. While patientswith rheumatic ASmean age of presentation
was 44 years with predominant symptom as dyspnoea.
Have signiﬁcant degree of left ventricular hypertrophy and
diastolic dysfunction.
4. Degenerative AS group mean age of presentation was 59
years and most common symptom dyspnoea 72%. Have
signiﬁcantly more left ventricular hypertrophy and dia-
stolic dysfunction compared to other etiologies. They also
have more elevated LV ﬁlling pressures (E/e0) possibly
because of higher age of patients andmayhave preexisting
myocardial disease. Ischemic heart disease, diabetes
mellitus type 2, systemic hypertension are common in
this age group.
5. GLS assessment of patients with preserved LV systolic
function LVEF>50%. Showed signiﬁcant abnormality in GLS
suggestive of subclinical myocardial systolic dysfunction.
Emphases the recommendation for routine use of strain
assessment in patients of valvular AS.
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Background: Acenocoumarol, an oral vitamin K antagonist, is a
commonly prescribed anticoagulant following valve replacement
surgery in India and has a narrow therapeutic index. This study
aimed at investigating the prevalence of vitamin K 2,3 epoxide
reductase C1 (VKORC1) gene polymorphism in south Indian
patients and its inﬂuence on the inter-individual variability in
response to acenocoumarol therapy.
Methods: The study cohort included 205 rheumatic heart disease
patients with mechanical heart valves, on acenocoumarol therapy
with a stable therapeutic INR between 2 and 3.5. VKORC1 1639G>A
and 1173C>T genotypes were determined by PCR-RFLP method.
Correlation between genotypes and the acenocoumarol dosage
was evaluated.
Results: Themost prevalent genotypes of VKORC1 in our studywas
wild homozygous GG for-1639G>A and CC for 1173C>T (57.6%).
This was followed by heterozygous GA & CT at 36.1% and AA & TT
at 6.3%. The Allele frequency for both G and C was 0.76 and for A
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and T 0.24. There was complete linkage disequilibrium between
1639G>A and 1173C>T (r2 = 0.98, D0 = 1.0, LOD = 74.02).
The wild type (GG and CC) of VKORC1 required a mean acenocou-
marol dose of 2.78 mg, a moderately higher dose as compared to
2.39 mg for heterozygous GA and CT and 2.29 mg for homozygous
AA and TT ( p value 0.023). Only inmale patients, bearing A allele of
VKORC1 gene independently increased the odds of requiring a low
dosage of acenocoumarol (adjusted OR 1.65 at 95%CI, class interval
0.99-2.76, p value-0.05). Both the wild type and alleles had a lower
mean dose requirement when the patients were concomitantly
prescribed Furosemide and Digoxin.
Conclusions: Heterozygous patients were more common in
our study cohort compared to previous studies on Indian popula-
tion and require a lower mean acenocoumarol dosage. Male
patients bearing 'A' allele and patients concomitantly using Fur-
osemide and Digoxin require a lower dosage. However co-pre-
scribing low dose aspirin has no inﬂuence on the mean dose
requirement.
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Background: Major complications in infective endocarditis (IE)
remain high even in the current era of critical cardiac care. A
reliable parameter that predicts complications and identiﬁes
patients requiring urgent surgery is lacking.
Purpose: Our aim was to study the value of baseline clinical,
laboratory and microbiological parameters in IE patients. We
focussed on the independent utility of inﬂammatory markers like
leukocyte count (TLC), erythrocyte sedimentation ratio (ESR) and
C-reactive protein (CRP) regardless of blood culture positivity or
vegetation size.
Methods: This was a prospective study on consecutive IE patients
(by modiﬁed Duke criteria) who were admitted to our tertiary care
centre between 2012 and 2015. Predeﬁned laboratory-microbiolo-
gical sampling protocols and antibiotic-initiation protocols were
followed. Peak levels of CRP and ESR in the ﬁrst 3 days of admission
were documented.
Results: Out of 101 patients treated, 71 patients with deﬁnite IE by
Duke criteria were analysed. Mean age was 43 16 years. Blood
cultures were positive in 55% (n = 39) of which Staphylococcus was
themost common.Major complicationsoccurred in 72% (n = 53) and
in-hospitalmortalitywas31%(n = 22).MeanESRandCRP levelswere
102 31 mm/hr and 51 20 mg/l respectively. In multivariate ana-
lysis, high CRP levels were independently predictive of poor out-
comes (p < 0.001) including major complications, embolic events
and need for urgent surgery. A CRP >30 mg/l predicted complica-
tions with a sensitivity of 91% and speciﬁcity of 82%. CRP level
>40 mg/l predicted mortality (relative risk = 8.12, p = 0.003).
Conclusion:Major complications andmortality continue to remain
high for IE. The interim results identify the independent value of
CRP levels as a marker for early risk-stratiﬁcation of IE patients. A
biomarker based algorithm at admission may favourably impact
treatment outcomes in IE. This study has set the stage for further
randomised trials in this regard.
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Case presentation: A 13 years old girl presented to us with history
of dyspnea on exertion since 15days. On examination she had a
pansystolic murmur in mitral area and an ejection systolic mur-
mur in aortic area. ECG done showed RBBB with features sugges-
tive of biatrial enlargement. Patient did not give any previous
history of rheumatic fever. Patient was diagnosed to have rheu-
matic heart disease and was advised to get 2D echocardiography.
2D echo showed dilated LA, RA and RV. The anterior mitral leaﬂet
was thick and domed with restricted movement of PML and Dop-
pler interrogation revealed a peak gradient of 31 mmHg andmean
gradient of 22 mm of Hg. Colour Doppler study showed severe
mitral regurgitation. Aortic valve was thickened and was showing
restricted movement. Doppler study showed mild AR with severe
AS (peak gradient 82 mmof Hg andmean gradient of 47 mmof Hg).
There was organic tricuspid valve disease with severe TR and
severe TS (peak gradient 14 mm of Hg and mean gradient of
7 mm of Hg). Pulmonary valve was normal except for mild PR
probably due to associated severe PAH. Patient also had LV con-
centric hypertrophy with normal LVEF. Final diagnosis of rheu-
matic heart disease with severe triple valve involvement with
severe PAH was made and patient was sent for surgery.
Discussion: Rheumatic heart disease in India is characterized by
rapid progression and death at younger age. Nearly 32% of
patients die before the age of 20 years. In an autopsy study
conducted on 144 children below the age of 18 years mitral valve
was affected in 100%of cases. Involvement of aortic, tricuspid and
pulmonary valves was seen in 63.89%, 54.86% and 12.5% respec-
tively. Multivalvular disease was noted in 75.69% cases; but dou-
ble valve and triple valve disease which possibly would have
required surgerywas present in only 8.33% and 3.5% cases respec-
tively. This case showed severe rheumatic involvement of aortic,
mitral, and tricuspid valve in a juvenile patient with is very rarely
seen.
Conclusion: In India, rheumatic fever is endemic and remains one
of the major causes of cardiovascular disease, accounting for
nearly 25–45% of the acquired heart disease. This case demon-
strates smoldering rheumatic activity that can be seen in Indian
children at a very young age leading to triple valve involvement.
Not only the cost of treatment in such patients are phenomenal,
the morbidity and mortality is also enormous. Hence ‘‘Prevention
is better than cure’’ is very apt for rheumatic fever.
Percutaneous balloon mitral
valvuloplasty during pregnancy:
Retrospective analysis of pregnancy
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Introduction: Rheumatic mitral valve stenosis is most common
lesion and important contributor of mortality in pregnancy. Per-
cutaneous balloonmitral valvuloplasty (BMV) is the intervention of
choice during pregnancy. Given the procedural complexities and
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